within Pharmacolibrary.Drugs.C_CardiovascularSystem.C05B_AntivaricoseTherapy.C05BA53_HeparinCombinations;

model HeparinCombinations
  extends Pharmacolibrary.Drugs.ATC.C.C05BA53;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C05BA53</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Heparin, in combination preparations, is an anticoagulant used for the prevention and treatment of thromboembolic disorders such as deep vein thrombosis and pulmonary embolism. It acts by potentiating the activity of antithrombin III, thereby inhibiting the formation of fibrin clots. This drug is typically administered parenterally due to poor oral bioavailability and is used in both inpatient and outpatient settings. Heparin combinations may contain local anesthetics or other agents. Heparin and its combinations remain approved and widely used today.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for typical adult patients receiving heparin combination preparations; no specific publication found for C05BA53 combination products.</p><h4>References</h4><ol><li><p>Kandrotas, RJ (1992). Heparin pharmacokinetics and pharmacodynamics. <i>Clinical pharmacokinetics</i> 22(5) 359–374. DOI:<a href=\"https://doi.org/10.2165/00003088-199222050-00003\">10.2165/00003088-199222050-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1505142/\">https://pubmed.ncbi.nlm.nih.gov/1505142</a></p></li><li><p>Verstraete, M (1990). Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins. <i>Drugs</i> 40(4) 498–530. DOI:<a href=\"https://doi.org/10.2165/00003495-199040040-00003\">10.2165/00003495-199040040-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1964634/\">https://pubmed.ncbi.nlm.nih.gov/1964634</a></p></li><li><p>Ofosu, FA (1998). Pharmacological actions of sulodexide. <i>Seminars in thrombosis and hemostasis</i> 24(2) 127–138. DOI:<a href=\"https://doi.org/10.1055/s-2007-995831\">10.1055/s-2007-995831</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9579633/\">https://pubmed.ncbi.nlm.nih.gov/9579633</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end HeparinCombinations;
